Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies
MONDO:0035663Also known as: NMOSD with anti-AQP4 antibodies, Neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibodies
13 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Stem cells injected into spine to fight rare disease Flare-Up
Disease control Not yet recruitingThis early-phase trial tests whether injecting stem cells from a relative's bone marrow into the spine is safe for people with a severe relapse of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the optic nerves and spinal cord. Only 6 adult…
Phase: PHASE1 • Sponsor: Corestemchemon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Experimental CAR t treatment targets root cause of rare nerve disease
Disease control Not yet recruitingThis early-phase trial tests whether a new CAR T cell therapy called CC-97540 is safe for people with a rare autoimmune disease called neuromyelitis optica (NMOSD). The study will enroll 5 adults who are stable on current treatments. Researchers will check for side effects and wh…
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC